|
US654472A
(en)
*
|
1900-02-03 |
1900-07-24 |
George A Mayer |
Hub-attaching device.
|
|
DE1643310A1
(de)
|
1966-12-29 |
1971-06-03 |
Dow Chemical Co |
4-Alkyl-2,5-dimethoxy-alpha-methyl-phenaethylamin und seine pharmakologisch vertraeglichen Salze
|
|
US4099012A
(en)
|
1975-08-28 |
1978-07-04 |
Ciba-Geigy Corporation |
2-pyrazolyl-benzophenones
|
|
DE2926517A1
(de)
|
1979-06-30 |
1981-01-15 |
Beiersdorf Ag |
Substituierte 3-aryl-pyrazole und 5-aryl-isoxazole und verfahren zu ihrer herstellung
|
|
DE2928485A1
(de)
|
1979-07-14 |
1981-01-29 |
Bayer Ag |
Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
|
|
IL61721A
(en)
|
1980-12-16 |
1984-03-30 |
Blank Izhak |
Nitroglycerin preparations
|
|
US4555399A
(en)
|
1983-11-18 |
1985-11-26 |
Key Pharmaceuticals, Inc. |
Aspirin tablet
|
|
US4985352A
(en)
|
1988-02-29 |
1991-01-15 |
The Trustees Of Columbia University In The City Of New York |
DNA encoding serotonin 1C (5HT1c) receptor, isolated 5HT1c receptor, mammalian cells expressing same and uses thereof
|
|
IT1227626B
(it)
|
1988-11-28 |
1991-04-23 |
Vectorpharma Int |
Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
|
|
EP0412798A3
(en)
|
1989-08-08 |
1992-07-01 |
Merck Sharp & Dohme Ltd. |
Substituted pyridines, their preparation, formulations and use in dementia
|
|
US5661024A
(en)
|
1989-10-31 |
1997-08-26 |
Synaptic Pharmaceutical Corporation |
DNA encoding a human serotonic (5-HT2) receptor and uses thereof
|
|
US5077409A
(en)
|
1990-05-04 |
1991-12-31 |
American Cyanamid Company |
Method of preparing bis-aryl amide and urea antagonists of platelet activating factor
|
|
US5128351A
(en)
|
1990-05-04 |
1992-07-07 |
American Cyanamid Company |
Bis-aryl amide and urea antagonists of platelet activating factor
|
|
JPH04334357A
(ja)
|
1991-05-02 |
1992-11-20 |
Fujirebio Inc |
酵素阻害作用を有するアシル誘導体
|
|
FR2682379B1
(fr)
|
1991-10-09 |
1994-02-11 |
Rhone Poulenc Agrochimie |
Nouveaux phenylpyrazoles fongicides.
|
|
FR2690440B1
(fr)
|
1992-04-27 |
1995-05-19 |
Rhone Poulenc Agrochimie |
Arylpyrazoles fongicides.
|
|
US5905080A
(en)
|
1993-08-20 |
1999-05-18 |
Smithkline Beecham, P.L.C. |
Amide and urea derivatives as 5HT1D receptor antagonists
|
|
FR2722369B1
(fr)
|
1994-07-13 |
1998-07-10 |
Rhone Poulenc Agrochimie |
Compositions fongicides a base de derives 3-phenyl-pyrazoles pour le traitement du materiel vegetal de multiplication, nouveaux derives 3-phenyl-pyrazoles et leurs applications fongicides
|
|
EP0784612A1
(en)
|
1994-10-04 |
1997-07-23 |
Fujisawa Pharmaceutical Co., Ltd. |
Urea derivatives and their use as acat-inhibitors
|
|
CA2135253A1
(en)
|
1994-11-07 |
1996-05-08 |
Michael Dennis |
Compound screening based on a window of chemical-messenger-independent activity
|
|
US6540981B2
(en)
|
1997-12-04 |
2003-04-01 |
Amersham Health As |
Light imaging contrast agents
|
|
RO115522B1
(ro)
|
1995-02-02 |
2000-03-30 |
Smithkline Beecham P.L.C. |
Derivaţi de indolină, procedee pentru prepararea acestora, compoziţii farmaceutice care îi conţin şi metodă de tratament
|
|
EP0809492A4
(en)
|
1995-02-17 |
2007-01-24 |
Smithkline Beecham Corp |
IL-8 RECEPTOR ANTAGONISTS
|
|
US5856326A
(en)
|
1995-03-29 |
1999-01-05 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
DK0822808T3
(da)
|
1995-04-20 |
2000-10-09 |
Eurand Int |
Kompositmateriale med natriumstivelsesglycolat som bærermateriale og produkter deraf
|
|
US5861431A
(en)
|
1995-06-07 |
1999-01-19 |
Iotek, Inc. |
Incontinence treatment
|
|
AU6526896A
(en)
|
1995-07-22 |
1997-02-18 |
Rhone-Poulenc Rorer Limited |
Substituted aromatic compounds and their pharmaceutical use
|
|
US6054472A
(en)
|
1996-04-23 |
2000-04-25 |
Vertex Pharmaceuticals, Incorporated |
Inhibitors of IMPDH enzyme
|
|
US6005008A
(en)
|
1996-02-16 |
1999-12-21 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
|
GB9607219D0
(en)
|
1996-04-04 |
1996-06-12 |
Smithkline Beecham Plc |
Novel compounds
|
|
US6417393B1
(en)
|
1996-05-24 |
2002-07-09 |
Neurosearch A/S |
Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
|
|
AU2962297A
(en)
|
1996-05-24 |
1998-01-05 |
Neurosearch A/S |
Phenyl derivatives useful as blockers of chloride channels
|
|
CZ425698A3
(cs)
|
1996-06-27 |
1999-06-16 |
Smithkline Beecham Corporation |
Antagonista IL-8 receptoru
|
|
WO1998000016A1
(en)
|
1996-07-01 |
1998-01-08 |
Sepracor, Inc. |
Methods and compositions for treating urinary incontinence using enantiomerically enriched (r,r)-glycopyrrolate
|
|
WO1998000133A1
(en)
|
1996-07-01 |
1998-01-08 |
Sepracor, Inc. |
Methods and compositions for treating urinary incontinence using enantiomerically enriched (s,s)-glycopyrrolate
|
|
ATE314054T1
(de)
|
1996-10-25 |
2006-01-15 |
Shire Lab Inc |
Osmotisches verabreichungssystem für lösliche dosen
|
|
JP2001508767A
(ja)
|
1996-12-02 |
2001-07-03 |
藤沢薬品工業株式会社 |
５―ｈｔ拮抗作用を有するインドール―ウレア誘導体
|
|
US6420541B1
(en)
|
1998-04-14 |
2002-07-16 |
Arena Pharmaceuticals, Inc. |
Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
|
|
US6541209B1
(en)
|
1997-04-14 |
2003-04-01 |
Arena Pharmaceuticals, Inc. |
Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
|
|
US6696475B2
(en)
|
1997-04-22 |
2004-02-24 |
Neurosearch A/S |
Substituted phenyl derivatives, their preparation and use
|
|
TR199902593T2
(xx)
|
1997-04-22 |
2000-03-21 |
Neurosearch A/S |
�kame edilmi� fenil t�revleri, bunlar�n haz�rlanmas� ve kullan�m�.
|
|
US6028083A
(en)
*
|
1997-07-25 |
2000-02-22 |
Hoechst Marion Roussel, Inc. |
Esters of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol
|
|
CA2294064A1
(en)
|
1997-07-29 |
1999-02-11 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
|
AU750125B2
(en)
|
1997-08-27 |
2002-07-11 |
Hexal Ag |
New pharmaceutical compositions of meloxicam with improved solubility and bioavailability
|
|
BR9813331A
(pt)
|
1997-10-31 |
2000-08-22 |
Aventis Pharma Ltd |
Composto, uso do mesmo, composição farmacêutica, processo para o tratamento de um paciente humano ou animal não humano que sofra ou esteja sujeito a condições que possam ser melhoradas pela administração de um inibidor da adesão celular mediada pela a4b1, e, resina
|
|
JPH11183942A
(ja)
|
1997-12-19 |
1999-07-09 |
Nippon Mitsubishi Oil Corp |
エレクトロクロミック素子
|
|
US7517880B2
(en)
|
1997-12-22 |
2009-04-14 |
Bayer Pharmaceuticals Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
|
BR9814375A
(pt)
|
1997-12-22 |
2002-05-21 |
Bayer Ag |
Inibição de raf cinase usando difenil uréias substituìdas simétricas e assimétricas
|
|
JP3887769B2
(ja)
|
1997-12-22 |
2007-02-28 |
バイエル コーポレイション |
対称および非対称ジフェニル尿素を用いるｐ３８キナーゼの阻害
|
|
MXPA00010060A
(es)
|
1998-04-14 |
2004-04-23 |
Arena Pharm Inc |
Receptores de serotonina humana constitutivamente activados, no endogenos y moduladores de molecula pequenos de los mismos.
|
|
US6140509A
(en)
|
1998-06-26 |
2000-10-31 |
Arena Pharmaceuticals, Inc. |
Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
|
|
GB9816263D0
(en)
|
1998-07-24 |
1998-09-23 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US6358698B1
(en)
|
1998-10-07 |
2002-03-19 |
Acadia Pharmacueticals Inc. |
Methods of identifying inverse agonists of the serotonin 2A receptor
|
|
OA11665A
(en)
|
1998-10-22 |
2004-12-08 |
Neurosearch As |
Substituted phenyl derivatives, their preparation and use.
|
|
US6150393A
(en)
*
|
1998-12-18 |
2000-11-21 |
Arena Pharmaceuticals, Inc. |
Small molecule modulators of non-endogenous, constitutively activated human serotonin receptors
|
|
US6180138B1
(en)
|
1999-01-29 |
2001-01-30 |
Abbott Laboratories |
Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption
|
|
CA2368631A1
(en)
|
1999-03-26 |
2000-10-05 |
Euro-Celtique S.A. |
Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
|
|
GB9909409D0
(en)
|
1999-04-24 |
1999-06-23 |
Zeneca Ltd |
Chemical compounds
|
|
US6469006B1
(en)
*
|
1999-06-15 |
2002-10-22 |
Bristol-Myers Squibb Company |
Antiviral indoleoxoacetyl piperazine derivatives
|
|
IT1312115B1
(it)
|
1999-06-24 |
2002-04-04 |
Nicox Sa |
Composti amorfi e relative composizioni farmaceutiche
|
|
SK1182002A3
(en)
|
1999-07-28 |
2002-11-06 |
Aventis Pharm Prod Inc |
Substituted oxoazaheterocyclyl compounds
|
|
US6541477B2
(en)
|
1999-08-27 |
2003-04-01 |
Scios, Inc. |
Inhibitors of p38-a kinase
|
|
WO2001021160A2
(en)
|
1999-09-23 |
2001-03-29 |
Axxima Pharmaceuticals Aktiengesellschaft |
Carboxymide and aniline derivatives as selective inhibitors of pathogens
|
|
US6531291B1
(en)
|
1999-11-10 |
2003-03-11 |
The Trustees Of Columbia University In The City Of New York |
Antimicrobial activity of gemfibrozil and related compounds and derivatives and metabolites thereof
|
|
EP1108720A1
(en)
|
1999-12-08 |
2001-06-20 |
Basf Aktiengesellschaft |
Herbicidal 2-Pyrazolyl-6-Aryloxy-Pyri(mi)dines
|
|
WO2001044193A1
(en)
|
1999-12-16 |
2001-06-21 |
Biostream Therapeutics |
1,3,4-substituted piperidine analogs and uses thereof in treating addictions
|
|
MXPA02006137A
(es)
|
1999-12-20 |
2002-12-05 |
Neuromed Tech Inc |
Bloqueadores del canal de calcio parcialmente saturados.
|
|
AU2001241927A1
(en)
|
2000-02-28 |
2001-09-12 |
Scios Inc. |
Inhibitors of p38-alpha kinase
|
|
FR2810979B1
(fr)
|
2000-06-29 |
2002-08-23 |
Adir |
Nouveaux derives de diphenyluree, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
GB0021885D0
(en)
|
2000-09-06 |
2000-10-18 |
Fujisawa Pharmaceutical Co |
New use
|
|
WO2002039987A2
(en)
|
2000-11-14 |
2002-05-23 |
Neurosearch A/S |
Use of malaria parasite anion channel blockers for treating malaria
|
|
AR035521A1
(es)
|
2000-12-22 |
2004-06-02 |
Lundbeck & Co As H |
Derivados de 3-indolina y composicion farmaceutica que los comprende
|
|
WO2002055496A1
(en)
|
2001-01-15 |
2002-07-18 |
Glaxo Group Limited |
Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
|
|
WO2002076464A1
(en)
|
2001-03-22 |
2002-10-03 |
Arena Pharmaceuticals, Inc. |
Anti-psychosis combination
|
|
ATE377413T1
(de)
|
2001-06-29 |
2007-11-15 |
Eurand Pharmaceuticals Ltd |
Verfahren für die thermodynamische aktivierung von wasserlöslichen arzneimitteln, die in vernetzten polymeren geladen sind
|
|
JP4733877B2
(ja)
|
2001-08-15 |
2011-07-27 |
富士通セミコンダクター株式会社 |
半導体装置
|
|
CA2461202C
(en)
|
2001-09-21 |
2011-07-12 |
Donald Pinto |
Lactam-containing compounds and derivatives thereof as factor xa inhibitors
|
|
WO2003062206A2
(en)
|
2002-01-23 |
2003-07-31 |
Arena Pharmaceuticals, Inc. |
Small molecule modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
|
|
US6743864B2
(en)
|
2002-03-12 |
2004-06-01 |
Basell Poliolefine Italia S.P.A. |
Polyolefin compositions having high tenacity
|
|
WO2004034963A2
(en)
|
2002-05-17 |
2004-04-29 |
Eisai Co., Ltd. |
Methods and compositions using cholinesterase inhibitors
|
|
WO2004028450A2
(en)
|
2002-09-24 |
2004-04-08 |
Arena Pharmaceuticals, Inc. |
Process of making phenylpyrazoles useful as selective 5ht2a modulators and intermediates thereof
|
|
US7635709B2
(en)
|
2002-09-26 |
2009-12-22 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Compositions and methods for bowel care in individuals with chronic intestinal pseudo-obstruction
|
|
TW200735568A
(en)
|
2002-11-08 |
2007-09-16 |
Interdigital Tech Corp |
Composite channel quality estimation techniques for wireless receivers
|
|
JPWO2004046110A1
(ja)
|
2002-11-15 |
2006-03-16 |
アステラス製薬株式会社 |
メラニン凝集ホルモン受容体拮抗剤
|
|
US7247628B2
(en)
*
|
2002-12-12 |
2007-07-24 |
Pfizer, Inc. |
Cannabinoid receptor ligands and uses thereof
|
|
US20060229335A1
(en)
|
2002-12-24 |
2006-10-12 |
Bradley Teegarden |
Diarylamine and arylheteroarylamine pyrazole derivatives as modulators of 5ht2a
|
|
US20040248850A1
(en)
|
2003-02-11 |
2004-12-09 |
Kemia, Inc. |
Compounds for the treatment of HIV infection
|
|
WO2004085433A2
(en)
|
2003-03-28 |
2004-10-07 |
Pharmacia & Upjohn Company Llc |
Positive allosteric modulators of the nicotinic acetylcholine receptor
|
|
GB0309781D0
(en)
|
2003-04-29 |
2003-06-04 |
Glaxo Group Ltd |
Compounds
|
|
FR2855825B1
(fr)
*
|
2003-06-04 |
2008-08-22 |
Aventis Pharma Sa |
Produits aryl-heteroaromatiques, compositions les contenant et utilisation
|
|
PT1558582E
(pt)
|
2003-07-22 |
2006-05-31 |
Arena Pharm Inc |
Derivados de diaril- e aril-heteroaril-ureia como moduladores do receptor de serotonina 5-ht2a uteis para a profilaxia e tratamento de desordens relacionadas com o mesmo
|
|
SI1558582T1
(sl)
|
2003-07-22 |
2006-06-30 |
Arena Pharm Inc |
Diaril in arilheteroaril secninski derivati kot modulatorji 5-HT2A serotoninskega receptorja, koristnega za profilakso in zdravljenje motenj, ki so znjim povezane
|
|
CA2533112A1
(en)
|
2003-08-13 |
2005-03-03 |
Christopher Hulme |
Melanin concentrating hormone receptor antagonist
|
|
US7091236B1
(en)
|
2003-08-20 |
2006-08-15 |
Sciele Pharma, Inc. |
Method for increasing the bioavailability of glycopyrrolate
|
|
US20050054691A1
(en)
|
2003-08-29 |
2005-03-10 |
St. Jude Children's Research Hospital |
Carboxylesterase inhibitors
|
|
EP1664042A1
(en)
|
2003-09-03 |
2006-06-07 |
Galapagos N.V. |
IMIDAZO 1,5-a PYRIDINE OR IMIDAZO 1,5-a PIPERIDINE DERIVATIVES AND THEIR USE FOR THE PREPARATION OF MEDICAMENT AGAINST 5-HT2A RECEPTOR-RELATED DISORDERS
|
|
DE10354604B4
(de)
*
|
2003-11-21 |
2016-10-13 |
Gesellschaft für Aufladetechnik und Spindelbau mbH |
Stufenlos schaltbares, magnetodynamisches Getriebe
|
|
WO2005077345A1
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Compounds for the treatment of gastro-esophageal reflux disease
|
|
CA2559038C
(en)
|
2004-03-23 |
2013-09-10 |
Arena Pharmaceuticals, Inc. |
Processes for preparing substituted n-aryl-n'-[3-(1h-pyrazol-5-yl) phenyl] ureas and intermediates thereof
|
|
US20060014705A1
(en)
|
2004-06-30 |
2006-01-19 |
Howitz Konrad T |
Compositions and methods for selectively activating human sirtuins
|
|
US20060172992A1
(en)
|
2004-08-13 |
2006-08-03 |
Eisai Co., Ltd. |
Therapeutic agent for overactive bladder resulting from cerebral infarction
|
|
JP2008509982A
(ja)
|
2004-08-16 |
2008-04-03 |
プロシディオン・リミテッド |
アリール尿素誘導体
|
|
US20060063754A1
(en)
|
2004-09-21 |
2006-03-23 |
Edgar Dale M |
Methods of treating a sleep disorder
|
|
WO2006045010A2
(en)
|
2004-10-20 |
2006-04-27 |
Resverlogix Corp. |
Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
|
|
AU2005302669A1
(en)
|
2004-10-27 |
2006-05-11 |
Neurogen Corporation |
Diaryl ureas as CB1 antagonists
|
|
US7563785B2
(en)
|
2004-10-29 |
2009-07-21 |
Hypnion, Inc. |
Quetiapine analogs and methods of use thereof
|
|
JP2008518935A
(ja)
|
2004-11-01 |
2008-06-05 |
セオ ホン ユー |
筋萎縮性側索硬化症の神経退行を減少させるための方法及び組成物
|
|
SA05260357B1
(ar)
|
2004-11-19 |
2008-09-08 |
ارينا فارماسيتو تيكالز ، أنك |
مشتقات 3_فينيل_بيرازول كمعدلات لمستقبل سيروتينين 5_ht2a مفيدة في علاج الاضطرابات المتعلقه به
|
|
GB0426313D0
(en)
|
2004-12-01 |
2005-01-05 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
WO2006060654A2
(en)
|
2004-12-01 |
2006-06-08 |
Divergence, Inc. |
Pesticidal compositions and methods
|
|
WO2006060762A2
(en)
|
2004-12-03 |
2006-06-08 |
Arena Pharmaceuticals, Inc. |
Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
DE102004061593A1
(de)
|
2004-12-21 |
2006-06-22 |
Abbott Gmbh & Co. Kg |
Substituierte N-heterocyclische Verbindungen und ihre therapeutische Verwendung
|
|
EP1831172B1
(en)
|
2004-12-28 |
2009-02-18 |
Council of Scientific and Industrial Research |
Substituted carbamic acid quinolin-6-yl esters useful as acetylcholinesterase inhibitors
|
|
WO2006076592A1
(en)
|
2005-01-14 |
2006-07-20 |
Cgi Pharmaceuticals, Inc. |
1,3 substituted diaryl ureas as modulators of kinase activity
|
|
EP1843762A1
(en)
|
2005-01-19 |
2007-10-17 |
Arena Pharmaceuticals, Inc. |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis or treatment of progressive multifocal leukoencephalopathy
|
|
CN101166516A
(zh)
|
2005-01-21 |
2008-04-23 |
特瓦制药工业有限公司 |
稳定的唑尼沙胺药物制剂及其制备方法
|
|
AR052886A1
(es)
|
2005-01-26 |
2007-04-11 |
Arena Pharm Inc |
Procedimientos para preparar fenilpirazol ureas sustituidas y para la obtencion de sus intermediarios de sintesis
|
|
EP1846415B1
(en)
|
2005-01-27 |
2012-08-01 |
Janssen Pharmaceutica NV |
Heterocyclic tetracyclic tetrahydrofuran derivatives as 5ht2 inhibitors in the treatment of cns disorders
|
|
GT200600042A
(es)
|
2005-02-10 |
2006-09-27 |
Aventis Pharma Inc |
Compuestos de bis arilo y heteroarilo sustituido como antagonistas selectivos de 5ht2a
|
|
WO2006089871A2
(en)
|
2005-02-23 |
2006-08-31 |
Neurosearch A/S |
Diphenylurea derivatives useful as erg channel openers for the treatment of cardiac arrhythmias
|
|
GB0504828D0
(en)
|
2005-03-09 |
2005-04-13 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
GB0505437D0
(en)
|
2005-03-17 |
2005-04-20 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
GB0505725D0
(en)
|
2005-03-19 |
2005-04-27 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
TWI320783B
(en)
|
2005-04-14 |
2010-02-21 |
Otsuka Pharma Co Ltd |
Heterocyclic compound
|
|
JP5049267B2
(ja)
|
2005-04-26 |
2012-10-17 |
ハイプニオン・インコーポレイテッド |
ベンズイソオキサゾールピペラジン化合物およびその使用方法
|
|
EP1734039A1
(en)
|
2005-06-13 |
2006-12-20 |
Esbatech AG |
Aryl urea compounds as BETA-secretase inhibitors
|
|
US8703805B2
(en)
|
2005-06-27 |
2014-04-22 |
Exelixis Patent Company Llc |
Modulators of LXR
|
|
US7754724B2
(en)
*
|
2005-06-30 |
2010-07-13 |
Dow Agrosciences Llc |
N-substituted piperazines
|
|
US8093401B2
(en)
|
2005-08-04 |
2012-01-10 |
Sirtris Pharmaceuticals, Inc. |
Sirtuin modulating compounds
|
|
US7544685B2
(en)
|
2005-08-17 |
2009-06-09 |
H. Lundbeck A/S |
2,3-dihydroindole compounds
|
|
AR055203A1
(es)
|
2005-08-31 |
2007-08-08 |
Otsuka Pharma Co Ltd |
Derivados de benzotiofeno con propiedades antipsicoticas
|
|
CN101272771A
(zh)
|
2005-09-29 |
2008-09-24 |
艾尼纳制药公司 |
可用于治疗相关病症的5－ht2a血清素受体调节剂的医药组合物
|
|
WO2007120600A2
(en)
|
2006-04-10 |
2007-10-25 |
Arena Pharmaceuticals, Inc. |
3-pyridinyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
GB0608655D0
(en)
|
2006-05-03 |
2006-06-14 |
Merck Sharp & Dohme |
Therapeutic Treatment
|
|
ES2536762T3
(es)
|
2006-05-18 |
2015-05-28 |
Arena Pharmaceuticals, Inc. |
Aminas primarias y sus derivados como moduladores del receptor de la serotonina 5-HT2A útiles para el tratamiento de trastornos relacionados con este
|
|
EP2051978A2
(en)
|
2006-05-18 |
2009-04-29 |
Arena Pharmaceuticals, Inc. |
Acetamide derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
JP5286254B2
(ja)
|
2006-05-18 |
2013-09-11 |
アリーナ ファーマシューティカルズ， インコーポレイテッド |
５−ｈｔ２ａセロトニンレセプター活性のモジュレーターとして有用なフェニルピラゾールの結晶形態および調製方法
|
|
CA2646076C
(en)
|
2006-05-18 |
2015-06-30 |
Arena Pharmaceuticals, Inc. |
Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
JP2010502618A
(ja)
|
2006-08-31 |
2010-01-28 |
アリーナ ファーマシューティカルズ， インコーポレイテッド |
セロトニン５−ｈｔ２ａ受容体のモジュレータとしてのベンゾフラン誘導体
|
|
TWI415845B
(zh)
|
2006-10-03 |
2013-11-21 |
Arena Pharm Inc |
用於治療與５-ｈｔ2ａ血清素受體相關聯病症之作為５-ｈｔ2ａ血清素受體之調節劑的吡唑衍生物
|
|
TW200823204A
(en)
|
2006-10-17 |
2008-06-01 |
Arena Pharm Inc |
Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine H3-receptor useful for the treatment of disorders related thereto
|
|
WO2008054748A2
(en)
|
2006-10-31 |
2008-05-08 |
Arena Pharmaceuticals, Inc. |
Indazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
US8097633B2
(en)
|
2006-11-15 |
2012-01-17 |
Rich Steven A |
Uses for quaternary ammonium anticholinergic muscarinic receptor antagonists in patients being treated for cognitive impairment or acute delirium
|
|
US9034890B2
(en)
|
2006-11-15 |
2015-05-19 |
Steven A. Rich |
Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseases
|
|
US8969402B2
(en)
|
2006-11-15 |
2015-03-03 |
Steven A. Rich |
Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseases
|
|
KR20090094125A
(ko)
*
|
2006-12-08 |
2009-09-03 |
엑셀리시스, 인코포레이티드 |
Ｌｘｒ 및 ｆｘｒ 조절자
|
|
WO2009023253A2
(en)
|
2007-08-15 |
2009-02-19 |
Arena Pharmaceuticals Inc. |
IMIDAZO[L,2-α]PYRIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
|
|
EP2508177A1
(en)
|
2007-12-12 |
2012-10-10 |
Glaxo Group Limited |
Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
|
|
WO2009123714A2
(en)
|
2008-04-02 |
2009-10-08 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
|
|
WO2010062321A1
(en)
|
2008-10-28 |
2010-06-03 |
Arena Pharmaceuticals, Inc. |
Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto
|
|
CN104739829B
(zh)
|
2008-10-28 |
2018-11-06 |
艾尼纳制药公司 |
用于治疗5-ht2a5-羟色胺受体相关障碍的5-ht2a5-羟色胺受体调节剂组合物
|
|
GB201111712D0
(en)
|
2011-07-08 |
2011-08-24 |
Gosforth Ct Holdings Pty Ltd |
Pharmaceutical compositions
|
|
EP2911670A1
(en)
|
2012-10-25 |
2015-09-02 |
Otsuka Pharmaceutical Co., Ltd. |
Prophylactic and/or therapeutic agent for behavioral and psychological symptoms associated with neurodegenerative disease or impulsive symptoms associated with mental disease containing brexpiprazole or salt thereof
|
|
WO2014085362A1
(en)
|
2012-11-27 |
2014-06-05 |
Acadia Pharmaceuticals Inc. |
Methods for the treatment of parkinson's disease psychosis using pimavanserin
|
|
KR101472682B1
(ko)
|
2013-07-23 |
2014-12-15 |
고려대학교 산학협력단 |
메타물질 제조 방법, 이에 의해 제조된 메타물질 구조 필름 및 이를 이용한 광학 이미징 시스템
|
|
WO2017011767A2
(en)
|
2015-07-15 |
2017-01-19 |
Axovant Sciences Ltd. |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease
|